Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles

Therapeutic options for amyotrophic lateral sclerosis (ALS) are still limited. Great hopes, however, are placed in growth factors that show neuroprotective abilities (e.g., nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and vascular endothelial growth factor (VEGF)) and in the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Mol Sci
Asıl Yazarlar: Sobuś, Anna, Baumert, Bartłomiej, Litwińska, Zofia, Gołąb-Janowska, Monika, Stępniewski, Jacek, Kotowski, Maciej, Pius-Sadowska, Ewa, Kawa, Miłosz P., Gródecka-Szwajkiewicz, Dorota, Peregud-Pogorzelski, Jarosław, Dulak, Józef, Nowacki, Przemysław, Machaliński, Bogusław
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5983708/
https://ncbi.nlm.nih.gov/pubmed/29702606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19051312
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller